EUVIMEDEUVIMED entdecken
Crossref

Engineering Poly(ε-caprolactone)-Based Maleimide−Enediyne Micelles for Next-Generation Anticancer Therapies

Abhi Bhadran, Godwin K Babanyinah, Himanshu Polara iD, Ashutosh Shrivastava, Orikeda Trashi, Rhiza Lyne Villone, Mai Phuong Vu, Gabriele Meloni iD, Jeremiah J Gassensmith iD, Michael C Biewer iD, Mihaela C Stefan iD

Biomacromolecules · 2026

DOI: 10.1021/acs.biomac.6c00893 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomacromolecules, 2026. Verfasst von Abhi Bhadran und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas75080, United States. Hauptthemen laut MEDLINE: Micelles, Polyesters, Enediynes, Maleimides. Die Arbeit nennt 61 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inspired by the DNA-cleaving potency of natural enediynes such as calicheamicin, we report the design and synthesis of maleimide−enediyne conjugates integrated into poly(ε-caprolactone) (PCL) as a next-generation platform for anticancer drug delivery. Maleimide-based enediynes typically suffer from poor aqueous solubility and nonspecific toxicity, addressed here by covalently incorporating enediyne groups into amphiphilic PCL block copolymers via post-polymerization functionalization. The resulting polymers form ∼120 nm spherical micelles with a critical micelle concentration of 9.1 × 10−4 mg mL−1, enhancing enediyne solubility, promoting tumor accumulation through the EPR effect, and enabling encapsulation of hydrophobic drugs such as doxorubicin. Electron paramagnetic resonance confirmed radical formation and Bergman cyclization under physiological conditions. Cell viability assays showed enediyne-induced death in MDA-MB-231 breast cancer cells, and the functionalized PCL exhibited in vitro DNA cleaving activity, demonstrating that maleimide−enediyne-functionalized PCL micelles are promising platforms for cancer chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicellesPolyestersEnediynesMaleimidesAntineoplastic AgentsBreast NeoplasmsHumansDoxorubicinCell Line, TumorCell SurvivalDrug Delivery Systems

Stichwörter der Autor:innen

Poly(ε-caprolactone)sbiodegradable polymerscalicheamicincancermaleimide−enediynes

Substanzen

MicellesPolyestersEnediynespolycaprolactoneMaleimidesDoxorubicinmaleimideAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of Texas at Dallas, Richardson, Texas75080, United States.

ORCID-Profile: Himanshu Polara, Gabriele Meloni, Jeremiah J Gassensmith, Michael C Biewer, Mihaela C Stefan

Zitieren

APA

Bhadran, A., Babanyinah, G. K., Polara, H., Shrivastava, A., Trashi, O., Villone, R. L., Vu, M. P., Meloni, G., Gassensmith, J. J., Biewer, M. C., & Stefan, M. C. (2026). Engineering Poly(ε-caprolactone)-Based Maleimide−Enediyne Micelles for Next-Generation Anticancer Therapies. Biomacromolecules. https://doi.org/10.1021/acs.biomac.6c00893

Vancouver

Bhadran A, Babanyinah GK, Polara H, Shrivastava A, Trashi O, Villone RL, et al. Engineering Poly(ε-caprolactone)-Based Maleimide−Enediyne Micelles for Next-Generation Anticancer Therapies. Biomacromolecules. 2026. doi:10.1021/acs.biomac.6c00893

BibTeX
@article{Bhadran2026,
  author = {Bhadran, Abhi and Babanyinah, Godwin K and Polara, Himanshu and Shrivastava, Ashutosh and Trashi, Orikeda and Villone, Rhiza Lyne and Vu, Mai Phuong and Meloni, Gabriele and Gassensmith, Jeremiah J and Biewer, Michael C and Stefan, Mihaela C},
  title = {Engineering Poly(ε-caprolactone)-Based Maleimide−Enediyne Micelles for Next-Generation Anticancer Therapies},
  journal = {Biomacromolecules},
  year = {2026},
  doi = {10.1021/acs.biomac.6c00893}
}
Kostenlos starten →